Cargando…

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease

Detalles Bibliográficos
Autor principal:	Vassar, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shanghai University of Sport 2016
Materias:	Special section on Physical Activity and Prevention of Alzheimer’s Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188930/ https://www.ncbi.nlm.nih.gov/pubmed/30356583 http://dx.doi.org/10.1016/j.jshs.2016.10.004

Ejemplares similares

Physical activity and prevention of Alzheimer's disease
por: Li, Rena, et al.
Publicado: (2016)

Mechanism of neurodegeneration through tau and therapy for Alzheimer's disease
por: Takashima, Akihiko
Publicado: (2016)

The microbiome, microbial-generated proinflammatory neurotoxins, and Alzheimer's disease
por: Lukiw, Walter J.
Publicado: (2016)

What do we know from clinical trials on exercise and Alzheimer's disease?
por: Shen, Yong, et al.
Publicado: (2016)

Biomarker-guided classification scheme of neurodegenerative diseases
por: Baldacci, Filippo, et al.
Publicado: (2016)

Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer’s disease using voxel-based analysis of amyloid plaques
por: Kim, Jae-Hun, et al.
Publicado: (2014)

Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis
por: Santos, Cláudia Y., et al.
Publicado: (2017)

Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease
por: Clark, Lindsay R., et al.
Publicado: (2017)

Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease
por: Zhu, Yanan, et al.
Publicado: (2017)

Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease
por: Zufferey, Valérie, et al.
Publicado: (2017)

Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report
por: Swardfager, Walter, et al.
Publicado: (2017)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
por: Vassar, Robert
Publicado: (2014)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease
por: Cole, S.L, et al.
Publicado: (2007)

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
por: Sachdev, Perminder S., et al.
Publicado: (2016)

Repetitive head impact exposure and later-life plasma total tau in former National Football League players
por: Alosco, Michael L., et al.
Publicado: (2016)

Pathobiology of Alzheimer's disease /
Publicado: (1995)

The Structured Interview for Insight and Judgment in Dementia: Development and validation of a new instrument to assess awareness in patients with dementia
por: Parrao, Teresa, et al.
Publicado: (2016)

Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders
por: Vijverberg, Everard G.B., et al.
Publicado: (2017)

Subsyndromal delirium compared with delirium, dementia, and subjects without delirium or dementia in elderly general hospital admissions and nursing home residents
por: Sepulveda, Esteban, et al.
Publicado: (2016)

Development of an instrument to assess social functioning in dementia: The Social Functioning in Dementia scale (SF-DEM)
por: Sommerlad, Andrew, et al.
Publicado: (2017)

Sleep-wake cycle disturbances in elderly acute general medical inpatients: Longitudinal relationship to delirium and dementia
por: FitzGerald, James M., et al.
Publicado: (2017)

A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
por: Dobrowolska Zakaria, Justyna A, et al.
Publicado: (2018)

Alcohol use disorder is associated with higher risks of Alzheimer's and Parkinson's diseases: A study of US insurance claims data
por: Zhang, Pengyue, et al.
Publicado: (2022)

Enhancing the Use of Vehicle Alcohol Interlocks With Emerging Technology
por: Voas, Robert B.
Publicado: (2014)

Preventing Alcohol-Related Problems on College Campuses: Summary of the Final Report of the NIAAA Task Force on College Drinking
por: Saltz, Robert F.
Publicado: (2004)

Convivir con Alzheimer /
por: Matías-Guiu Guía, Jordi
Publicado: (2004)

Enfermedad de Alzheimer
Publicado: (1990)

Amyloid-ß-directed immunotherapy for Alzheimer's disease
por: Lannfelt, L, et al.
Publicado: (2014)

Enfermedad de Alzheimer : una guía para la familia /
por: Powell, Lenore S.
Publicado: (1988)

Enfermedad de Alzheimer : respuestas a las preguntas más frecuentes /
por: Hodgkinson, Liz
Publicado: (1996)

La enfermedad de Alzheimer : un trastorno neuropsiquiátrico
Publicado: (2004)

La enfermedad de alzheimer : saber, prevenir, tratar, vivir con la enfermedad /
por: Furtmayr-Schuh, Annelies
Publicado: (1995)

La enfermedad de Alzheimer : bases fisiopatológicas, diagnóstico y alternativas de tratamiento /
por: Juárez García, Luz del Carmen
Publicado: (1997)

Alzheimer : la vida de un médico, la historia de una enfermedad
por: Maurer, Konrad, 1943-
Publicado: (2006)

Electronic Feedback in College Student Drinking Prevention and Intervention
por: Cronce, Jessica M., et al.
Publicado: (2014)

Putting the Screen in Screening: Technology-Based Alcohol Screening and Brief Interventions in Medical Settings
por: Harris, Sion Kim, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7abvk8qsq0vvkg2lcin359402l